Johnson & Johnson

Pharmaceuticals
JNJ
$ 161 (0.07)%
Share price
$ 387 bn
Market Cap
$ 395 bn
Enterprise Value

Carbon footprint

1.9 Ton
GHG emissions per $ 1 mln investment
0.06x the weighted average for S&P 500
FY2020
How is this calculated?
-20%
YOY change in GHG emissions
Stronger than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Johnson & Johnson's GHG emissions (market-based) (Kt of CO2e)
Johnson & Johnson's Carbon intensity (Tons per 1 USDm)

Johnson & Johnson's carbon footprint

Johnson & Johnson reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 748 Kt (-186 /-19.9% y-o-y). Also positively, carbon intensity plunged to 9.1 t (-2.3 /-20.2% y-o-y).

Johnson & Johnson's Scope 3 emissions declined marginally to 20,373 Kt (-128 /-0.6% y-o-y). There has been no consistent trend in recent years.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Johnson & Johnson also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* Johnson & Johnson also commits that 80% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2028. * The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.

Company environmental metrics

Show more...